Skip to content

ICF in Secondary Prevention of Cardiovascular Disease

The Use of ICF Classification System in Secondary Prevention of Cardiovascular Disease Among Others Ischemic and Hemorrhagic Stroke.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04590287
Enrollment
120
Registered
2020-10-19
Start date
2020-08-15
Completion date
2020-10-01
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Risk Factor, Cardiovascular, Secondary Prevention

Brief summary

The aim of this study was to develop a practical protocol based on the ICF(The International Classification of Functioning, Disability, and Health) the risk factors of cardiovascular disease (CVD) in secondary prevention.

Detailed description

The original ICF assessment sheet contains CVD risk factor categories, such as comorbidities (depressive disorders, insomnia, heart rhythm and heart rate disorders, carotid artery disease, and hypertension), measures of liver and renal impairment, disorders of carbohydrate and lipid metabolism). The evaluation criteria for each category were determined based on recommendations defined in the ESC, AHA, EFSD, and KIDIGO guidelines.

Interventions

None listed

Sponsors

Poznan University of Medical Sciences
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* the first episode of ischemic stroke or hemorrhagic stroke, * full medical documentation with a description of the above-mentioned risk factors

Exclusion criteria

* another neurological disease: brain tumor, trauma craniocerebral * incomplete medical history - no data on assessed risk factors CVD

Design outcomes

Primary

MeasureTime frameDescription
emotional functionsfirst examination on admissionsymptoms of depression
sleep functionsfirst examination on admissionsymptoms of insomnia
heart ratefirst examination on admissionheart rate per minute
heart rhythmfirst examination on admissionheart rhythm interpreting ECG (regular or irregular)
functions of arteriesfirst examination on admissioncarotid stenosis \[%\]
increased blood pressurefirst examination on admissionblood pressure value \[mm/Hg\]
functions related to the coagulation of blood.first examination on admissionInternational Normalised Ratio (INR) testing
Glycosylated hemoglobinfirst examination on admissionHbA1c \[%\]
lipid metabolism.first examination on admissionLDL \[mg/dL\]

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026